AI Analysis AI Analysis of ACRS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ACRS to Watchlist?
Some Reasons Why To Add ACRS:
  • +207.6% price growth over the last year
  • +81.6% YTD performance
  • High gross margin of 76.3%
PDF

Aclaris Therapeutics stock price down 4.56% on Friday
(Updated on Jul 24, 2026)

Buy or Hold candidate since Jun 22, 2026 Gain 8.06%

The Aclaris Therapeutics stock price fell by -4.56% on the last day (Friday, 24th Jul 2026) from $5.48 to $5.23. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.95% from a day low at $5.21 to a day high of $5.52. The price has fallen in 7 of the last 10 days and is down by -6.27% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -119 thousand shares and in total, 761 thousand shares were bought and sold for approximately $3.98 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 24.62% during the next 3 months and, with a 90% probability hold a price between $5.83 and $7.38 at the end of this 3-month period.

ACRS Signals & Forecast

The Aclaris Therapeutics stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $5.52. On a fall, the stock will find some support from the long-term average at approximately $5.05. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -8.41%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Aclaris Therapeutics stock

Aclaris Therapeutics finds support from accumulated volume at $5.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.310 between high and low, or 5.95%. For the last week, the stock has had daily average volatility of 4.83%.

Our recommended stop-loss: $4.94 (-5.63%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations (ACRS) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Aclaris Therapeutics to open at $5.32, and during the day (based on 14 day Average True Range), to move between $5.08 and $5.38, which gives a possible trading interval of +/-$0.290 (+/-5.71%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 5.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.29 (1.15%) than the support at $5.00 (4.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Aclaris Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aclaris Therapeutics stock to perform well in the short-term.

Current score: 2.020 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $5.32 ( 1.72%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ACRS Performance

Trading levels for ACRS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.63 7.65%
R2 5.51 5.38%
R1 5.44 3.99%
Price 5.23
S1 5.20 -0.543%
S2 5.13 -1.94%
S3 5.01 -4.21%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.60 7.07%
R2 5.34 2.10%
R1 5.29 1.15%
Price 5.23
S1 5.00 -4.40%
S2 4.50 -13.96%
S3 4.34 -17.02%

FAQ

What is the symbol for Aclaris Therapeutics Stock and on which exchange is it traded?
The symbol for Aclaris Therapeutics is ACRS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aclaris Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Aclaris Therapeutics stock to perform well in the short-term.

How to buy Aclaris Therapeutics Stock?
Aclaris Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aclaris Therapeutics Stock.

What's the current price of Aclaris Therapeutics Stock?
As of the end of day on the Jul 24, 2026, the price of an Aclaris Therapeutics (ACRS) share was $5.23.

What is the 52-week high and low for Aclaris Therapeutics Stock?
The 52-week high for Aclaris Therapeutics Stock is $5.88 and the 52-week low is $1.47.

What is the market capitalization of Aclaris Therapeutics Stock?
As of the Jul 24, 2026, the market capitalization of Aclaris Therapeutics is 630.712M.

When is the next earnings date for Aclaris Therapeutics?
The upcoming earnings date for Aclaris Therapeutics is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT ACLARIS THERAPEUTICS
Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE